Significant increase in volume has been observed in Tatva Chintan Pharma Chem Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Tatva Chintan Pharma Chem Limited has submitted their response.
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE flagged an unusual spike in trading volume of Tatva Chintan Pharma Chem shares and asked the company to clarify on 20 May 2025. On 21 May 2025, the company responded stating that it has been fully complying with SEBI's disclosure rules (Regulation 30 of LODR Regulations, 2015) and has not withheld any material or price-sensitive information. The company attributed the volume increase purely to market conditions and said it is market-driven, with no company-specific trigger.
This is a routine surveillance query from the exchange and not indicative of any regulatory action or negative news. For shareholders, it confirms there is no hidden undisclosed event behind the volume surge, though the exact market driver remains unclear.